Labiana Health, S.A. (BME:LAB)
Spain
· Delayed Price · Currency is EUR 4.780
0.00 (0.00%)
Last updated: Dec 4, 2025, 12:07 PM CET
Labiana Health Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 71.67 | 67.37 | 59.7 | 60.76 | 59.44 | 60.1 | Upgrade
|
| Revenue Growth (YoY) | 8.37% | 12.86% | -1.75% | 2.21% | -1.09% | 18.53% | Upgrade
|
| Cost of Revenue | 31 | 28.47 | 27.03 | 29.99 | 26.15 | 26.06 | Upgrade
|
| Gross Profit | 40.67 | 38.91 | 32.67 | 30.77 | 33.29 | 34.04 | Upgrade
|
| Selling, General & Admin | 29.83 | 28.98 | 28.91 | 28.12 | 27.24 | 28.62 | Upgrade
|
| Other Operating Expenses | 0.66 | 0.59 | 0.61 | 0.04 | 0.44 | 0.59 | Upgrade
|
| Operating Expenses | 34.42 | 33.83 | 34.6 | 33 | 32.68 | 32.09 | Upgrade
|
| Operating Income | 6.25 | 5.08 | -1.92 | -2.23 | 0.61 | 1.95 | Upgrade
|
| Interest Expense | -5.2 | -4.84 | -3.29 | -2.11 | -2.13 | -1.94 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.02 | 0.01 | 0.62 | 0.13 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.13 | -0.07 | 0.05 | -0.13 | -0.67 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.04 | - | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | 0.95 | 0.21 | -5.11 | -3.84 | -2.06 | 0.03 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.11 | 0.12 | -0.02 | -0.01 | 0.01 | -0.03 | Upgrade
|
| Asset Writedown | -0.48 | -0.36 | -0.13 | -3.99 | -0.08 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.53 | Upgrade
|
| Pretax Income | 0.57 | -0.03 | -5.27 | -7.84 | -2.12 | 0.54 | Upgrade
|
| Income Tax Expense | -0.28 | -0.24 | -0.78 | 1.27 | -0.01 | -0.53 | Upgrade
|
| Earnings From Continuing Operations | 0.85 | 0.21 | -4.49 | -9.11 | -2.11 | 1.07 | Upgrade
|
| Minority Interest in Earnings | 0.05 | 0.05 | 0.07 | 0.17 | 0.34 | - | Upgrade
|
| Net Income | 0.9 | 0.25 | -4.42 | -8.94 | -1.78 | 1.07 | Upgrade
|
| Net Income to Common | 0.9 | 0.25 | -4.42 | -8.94 | -1.78 | 1.07 | Upgrade
|
| Net Income Growth | - | - | - | - | - | 63.61% | Upgrade
|
| Shares Outstanding (Basic) | 7 | - | 7 | - | 6 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | - | 7 | - | 6 | 6 | Upgrade
|
| Shares Change (YoY) | -0.65% | - | - | - | - | 7634.85% | Upgrade
|
| EPS (Basic) | 0.13 | - | -0.63 | - | -0.29 | 0.17 | Upgrade
|
| EPS (Diluted) | 0.13 | - | -0.63 | - | -0.29 | 0.17 | Upgrade
|
| EPS Growth | - | - | - | - | - | -97.89% | Upgrade
|
| Free Cash Flow | 0.07 | 4.18 | -3.48 | 1.9 | 1.61 | -0.46 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | - | -0.49 | - | 0.26 | -0.07 | Upgrade
|
| Gross Margin | 56.74% | 57.75% | 54.73% | 50.64% | 56.00% | 56.63% | Upgrade
|
| Operating Margin | 8.72% | 7.54% | -3.22% | -3.67% | 1.02% | 3.24% | Upgrade
|
| Profit Margin | 1.26% | 0.38% | -7.41% | -14.72% | -2.99% | 1.79% | Upgrade
|
| Free Cash Flow Margin | 0.09% | 6.20% | -5.84% | 3.12% | 2.71% | -0.76% | Upgrade
|
| EBITDA | 9.38 | 7.21 | 0.67 | 0.48 | 3.16 | 3.9 | Upgrade
|
| EBITDA Margin | 13.09% | 10.71% | 1.12% | 0.80% | 5.31% | 6.49% | Upgrade
|
| D&A For EBITDA | 3.13 | 2.13 | 2.59 | 2.71 | 2.55 | 1.95 | Upgrade
|
| EBIT | 6.25 | 5.08 | -1.92 | -2.23 | 0.61 | 1.95 | Upgrade
|
| EBIT Margin | 8.72% | 7.54% | -3.22% | -3.67% | 1.02% | 3.24% | Upgrade
|
| Advertising Expenses | - | 0.45 | 0.36 | 0.35 | 0.23 | 0.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.